BHF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Brighthouse Financial Inc (BHF) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows mixed signals, with recent financial underperformance, a downgrade in analyst ratings, and no significant positive trading signals. While the company has potential growth catalysts such as the Aquarian Capital merger, the current technical indicators and sentiment do not support an immediate buy decision.
The stock is currently oversold with an RSI_6 of 8.347, indicating potential for a short-term bounce. However, the MACD is negatively expanding (-0.376), and moving averages are converging, suggesting a lack of clear upward momentum. Key support levels are at $60.725 and $59.715, with resistance at $62.36 and $63.995. The stock is trading below the pivot level, which is bearish.
The $4.1 billion merger with Aquarian Capital has been approved by shareholders, which could enhance the company's market position and future growth potential. Additionally, the company reported a 39.7% YoY revenue growth in Q4 2025.
Recent earnings missed expectations with an EPS of $3.93 and revenue of $2.17 billion, both falling short of estimates. The company has underperformed the S&P 500 this year, with a 1.3% decline in share price. Analyst downgrades and a Zacks Rank of 4 (Sell) further indicate weak sentiment. Additionally, the company has only beaten EPS estimates 38% of the time and revenue estimates 25% of the time over the past two years.
In Q4 2025, revenue increased by 40.17% YoY to $1.689 billion. However, net income dropped by 82.66% YoY to $112 million, and EPS fell by 81.73% YoY to $1.94. This reflects significant profitability challenges despite revenue growth.
Barclays downgraded the stock to Equal Weight from Overweight with a $65 price target, citing cautious optimism on life insurers but noting that the Aquarian deal is already factored into the valuation. The downgrade reflects a neutral stance on the stock's near-term performance.
